Unregulated IL-23/IL-17 immune response in autoimmune diseases

Diabetes Research and Clinical Practice

Volumn 88, Issue 3, 2010, Pages 222-226

  Costa, Vinicius Silva ^a   Mattana, Teresa Cristina Colvara ^a   da Silva, Maria Elizabeth Rossi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Interleukin 23; Type 1 Diabetes

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL DESTRUCTION; CYTOKINE PRODUCTION; ENTERITIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; IMMUNOLOGY; IMMUNOTHERAPY; PATHOLOGY;

AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-17; INTERLEUKIN-23; T-LYMPHOCYTES, REGULATORY;

EID: 78349278907     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.03.014     Document Type: Review

References (25)

1. A. Pugliese, G.S. Einsenbarth, Type 1 diabetes melitus of man: genetic susceptibility and resistance, Oxford University, 2004.
2. Kunihiro I., Eiji K., Katsumi E. Recent advancement of understanding of type 1 diabetes and potential relevance to diabetic nephropathy. Am. J. Nephrol. 2007, 27:554-564.
3. Kingston H.G.M. Induction, function and regulation of IL-17 producing T cells. Eur. J. Immunol. 2008, 38:2636-2649.
4. Janette F.C., Maria I.R., Antonio R.C. Autoimmune inflammation from the Th17 perspective. Autoimmunity Rev. 2007, 6:169-175.
5. Elson C.O., Cong Y.W.C.T., Schoeb T.R., McClanahan T.K., Fick R.B., Kastelein R.A. Monoclonal anti-interleukin 23 reverses active colitis in T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370.
6. Anne C. Th 17 cells in inflammatory conditions. Rev. Diabetic Stud. 2006, 3:72-75.
7. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 205:233-240.
8. Ferretti S., Bonneau O., Dubois G.R., Jones C.E., Trifilieff A. IL17, produced by lymphocytes and neuthrophils, is necessary for lipopolysaccharide-induced airway neutrophilia:IL-15 as a possible trigger. J. Immunol. 2003, 170:2106-2112.
9. Fossiez F., Djossou O., Chomarat P., Flores R.L., Ait Y.S., Maat C.P.J., et al. T cell interleukin induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996, 183:2593-2603.
10. Yao Z., Painter F.W.C., Ulrich D., Macduff B.M., Spriggs M.K., Armitage R.J., et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 1995, 155:5483-5486.
11. Sarah L.G. Biology of recently discovered cytokines: interleukin-17-a unique inflammatory cytokine with roles in bones biology and arthritis. Arthritis Res. Ther. 2004, 6:240-247.
12. Anders Lindén A role for cytoplasmatic adaptor protein Act-1 in mediating IL-17 signaling. Science Stke. 2007, 398:1-8.
13. Aggarwal S., Gurney A.L. IL17: a protype member of an emerging cytokine family. J. Leukoc. Biol. 2002, 71:1-8.
14. Yoon C., Johnton S.C., Tang J., Stahl M., Tobin J.F., Somers W.S. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin 12. EMBO J. 2005, 19:3530-3541.
15. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12β1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002, 168:5699-5709.
16. Kevin J.M. The interleukin 23/interleukin 17 axis in intestinal inflammation. J. Intern. Med. 2008, 263:584-590.
17. Claire L.L., Mackenzie B.S., Wilson N.J., Malefyt R.W., Kastelein R.A., Cua D.J. IL-12 and IL 23: master regulators of innate and adaptative immunity. Immunol. Rev. 2004, 202:96-105.
18. Thomas K., Estelle B., Mohamed O., Vijay K.K. IL-17 and Th17 cells. Ann. Rev. Immunol. 2009, 27:485-517.
19. Kotake S. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 1999, 103:1345-1352.
20. Hwang S.Y., Kim J.P., Park M.K., Moon Y., Kim W.U., Kim H.Y. IL-17 induce production of IL-6 and IL-18 in rheumatoid arthritis synovial fibroblasts via NF-Kappa Beta and PI-3Kinase/AK 1-dependent pathways. Arthritis Res. Ther. 2004, 6:120-128.
21. Neurath M.F., Fuss I., Kelsall B.L., Stuber E., Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995, 182:1281-1290.
22. Carol B., Mark K.S. Regulation of innate and adaptative immune responses by the related cytokines IL-12, IL-23 and IL-27. Arch. Immunol. Ther. Exp. 2006, 54. 15-.
23. Kristina M.H., Alesio F., Dean L.M. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J. Immunol. 2008, 181:4457-4460.
24. Jeppe M.L. IL23 and Th17 mediated inflammation in human allergic contact dermatitis. J. Allergy Clin. Immunol. 2008, 3:1-7.
25. Mensah B. New member of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes. Ann. N.Y. Acad. Sci. 2006, 1079:157-160.